Quality, Patient Safety and Clinical Management

A global living systematic review and meta-analysis hub of emerging vaccines in pregnancy and childhood

2025, Quality, Patient Safety and Clinical Management, CIESP, Statistics, Data Management and Information Systems, Health Technology Assessment, Scientific Publications /

A. Ciapponi,A. Bardach,M. Berrueta,J. Ballivian,M. Brizuela,J. Caravario,N. Castellana,D. Commander, E. Couto,A. Mazzoni,V. Ortega, EPK Parker, JM Sambade, S. Florence,JP Smutny,K. Stegelmann,X.

Go to publication

A global living systematic review and meta-analysis hub of emerging vaccines in pregnancy and childhood See more "

Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis

2025, Quality, Patient Safety and Clinical Management, CIESP, Statistics, Data Management and Information Systems, Health Technology Assessment, Scientific Publications /

M. Berrueta,A. Ciapponi,A. Mazzoni,J. Ballivian,A. Bardach, J.M. Sambade,M. Brizuela,K. Stegelman,D. Commanded,EPK Parker,A. Stergachis,X. Xiong, FM Munoz and PM Buekens. Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis. Reproductive Health. 2025;22(1):10.1186/s12978-025-02004-2.

Go to publication

Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis See more "

A systematic review of maternal and perinatal health outcomes in the context of epidemic threats: towards the development of a core outcome set

2025, Quality, Patient Safety and Clinical Management, CIESP, Health Technology Assessment, Scientific Publications, and Child Health Research /

A. Mazzoni,M. Berrueta,V. Pingray,M. Babinska,C. Nigri,V. Ortega,F. Save,A. Ciapponi and M. Bonet. A systematic review of maternal and perinatal health outcomes in the context of epidemic threats: towards the development of a core outcome set. Maternal Health, Neonatology and Perinatology. 2025;11(1):10.1186/s40748-025-00215-w.

Go to publication

A systematic review of maternal and perinatal health outcomes in the context of epidemic threats: towards the development of a core outcome set See more "

Safety, immunogenicity, efficacy, and effectiveness of Lassa fever vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis

2025, Quality, Patient Safety and Clinical Management, CIESP, Statistics, Data Management and Information Systems, Health Technology Assessment, Scientific Publications /

J. Ballivian,M. Berrueta,A. Ciapponi, J.M. Sambade, K. Stegelmann,A. Mazzoni,A. Bardach,M. Brizuela,D. Commander, N. Castellana, EPK Parker, A. Stergachis,X. Xiong, FM Munoz and PM Buekens. Safety,

Go to publication

Safety, immunogenicity, efficacy, and effectiveness of Lassa fever vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis See more "

Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey

2024, Quality, Patient Safety and Clinical Management, CIESP, Scientific Publications /

Kruk ME, Kapoor NR, Lewis TP, Arsenault C, Boutsikari EC, Breda J, et al. Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey. Lancet Glob Health. 2024;12(1):e100-e11.

Go to publication

Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey See more "

Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity

2024, Quality, Patient Safety and Clinical Management, Scientific Publications /

Francoeur C, Alcamo AM, Robertson CL, Wainwright MS, Roa JD, Lovett ME, et al. Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity. JAMA Network Open. 2024;7(6):e2414122.

Go to publication

Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity See more "